Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kyn Therapeutics
Biotech
Ikena bags $120M to advance growing pipeline of cancer drugs
The round comes as Ikena prepares to add a TEAD inhibitor to its roster of clinical programs and advances a preclinical a first-in-class KRAS asset.
Nick Paul Taylor
Jan 5, 2021 8:00am
Celgene strikes Obsidian deal to boost CAR-T options
Jan 18, 2019 8:50am
I-O specialist Kyn comes out of stealth mode
Dec 14, 2017 8:55am
